USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
TUMOREND, LLC
Address:
755 DELGADO DR
BATON ROUGE, LA 70808-4731
Phone:
N/A
URL:
N/A
EIN:
126411915
DUNS:
830787011
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $299,043.00 2

Award List:

Structure-Activity Relationship of CM101 Tumor antiangiogenic agent with its lect

Award Year / Program / Phase:
2012 / SBIR / Phase I
Award Amount:
$150,000.00
Agency:
HHS
Principal Investigator:
Betty C. Zhu – 225-268-3052
Abstract:
DESCRIPTION (provided by applicant): CM101 is a polysaccharide tumor angiogenesis-targeting, complement activating, immune stimulating biological produced fermentatively from Group B Streptococcus. CM101 binds a capillary endothelium receptor, HP59, causing inflammatory cytokine cascades, recruiting… More

Immunoassay for diagnosis of invasive fungal disease

Award Year / Program / Phase:
2013 / SBIR / Phase I
Award Amount:
$149,043.00
Agency:
HHS
Principal Investigator:
Khushi L. Matta – 716-845-2397
Abstract:
DESCRIPTION: We have preliminary data for a small molecule glyco-decoy that specifically side-tracks the biosynthesis of the ligand for E-selection, and is a candidate for a novel anti-inflammatory. The three members E, L and P of the selection family areinflammatory adhesion molecules expressed… More